Among antiviral drugs encouraging results against COVID-19 on the testing demonstrated only as long as "Ramdevpir," said chief scientist who Sumia Swaminathan.
Speaking at a press conference of the foreign correspondents Association in Geneva office of the UN, she said that "Ramdevpir" has shown itself in reducing hospitalizations, but not mortality.
This drug urgently approved may 1 in the U.S. for the treatment COVID-19.
before it was developed to fight Ebola, but he's not managed to prove its effectiveness.
later, "Ramdevpir" proved to be useful in the treatment of infections SARS and MERS.
Patients with COVID-19, as a rule, a five-day course using the six vials of medications the total price of 2340 dollars.
During the entire period of the pandemic according to the who, the world revealed 10 710 005 cases COVID-19, died 517 877 people.
Most cases of infection reported in North and South America - 5 445 710 and Europe - 2 737 689.
Current information on the situation of COVID-19 in Russia and the world presented on the portal stopmanager. Of the Russian Federation.